Impact of everolimus-related interstitial lung disease on subsequent treatment in patients with metastatic breast cancer

20260 citationsJournal Articlegold Open Access

Authors

e-rILD may not influence the choice of following treatment or the development of drug-related ILD during subsequent treatments.

Good health and well-being

Published in: The Oncologist

Volume 31, Issue 4

Field-Weighted Citation Impact: 0.00